Paratek Pharmaceuticals (NASDAQ:PRTK) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on PRTK. Jefferies Financial Group cut Paratek Pharmaceuticals from a buy rating to […]

Related Keywords

Randallb Brenner ,Williamm Haskel , ,Institutional Trading Of Paratek Pharmaceuticals ,Polar Asset Management Partners Inc ,Hunting Hill Global Capital ,Paratek Pharmaceuticals ,Sigma Securities ,Topco Ltd ,Jefferies Financial Group ,Paratek Pharmaceuticals Inc ,News Ratings For Paratek Pharmaceuticals Daily ,Nasdaq ,Paratek Pharmaceuticals Trading ,Securities Exchange Commission ,Paratek Pharmaceuticals Company Profile ,Free Report ,Financial Group ,Get Free Report ,Exchange Commission ,General Counsel William ,Asset Management Partners ,Paratek Pharmaceuticals Daily ,Nasdaq Prtk ,Prtk ,Medical ,89354m10 ,Initiated Coverage ,Stocknews Com ,